BB Biotech AGXSWX:BION +0.63%33 3-Year RORE % is 141.52 as of Mar. 2026. GuruFocus rates XSWX:BION with a GF Score™ of 33/100. The stock has 4 warning signs investors should review. Among 1,295 Biotechnology companies, BB Biotech AG ranks better than 97.37% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
BB Biotech AG's 3-Year RORE % for the quarter that ended in Mar. 2026 was 141.52%.
The industry rank for BB Biotech AG's 3-Year RORE % or its related term are showing as below:
XSWX:BION's 3-Year RORE % is ranked better than 97.37% of 1295
companies
in the Biotechnology industry
Industry Median: -11.53
vs XSWX:BION: 141.52
BB Biotech AG (XSWX:BION) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
BB Biotech AG 3-Year RORE % Related Terms
BB Biotech AG 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for BB Biotech AG's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:BION vs VRTX, REGN, ALNY: 3-Year RORE % Comparison
For the Biotechnology subindustry, BB Biotech AG's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BB Biotech AG 3-Year RORE % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BB Biotech AG's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where BB Biotech AG's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
BB Biotech AG (XSWX:BION) has a 3-Year RORE % of 141.52 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on BB Biotech AG and its competitors. According to the industry distribution chart, BB Biotech AG ranks #34 out of 1295 companies in the Biotechnology industry, placing it in the top 2.6%.
Is BB Biotech AG's 3-Year RORE % too high?
BB Biotech AG's current 3-Year RORE % is 141.52. Based on the distribution chart, BB Biotech AG ranks #34 out of 1295 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, BB Biotech AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's 3-Year RORE % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #34 out of 1295 companies for 3-Year RORE %. This places BB Biotech AG in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Biotechnology company?
A good 3-Year RORE % depends on the Biotechnology industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on BB Biotech AG and its competitors. BB Biotech AG's current 3-Year RORE % is 141.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current 3-Year RORE % of 141.52. The current 3-Year RORE % is 141.52. BB Biotech AG's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current 3-Year RORE % is 141.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
33GF Score
Get the complete analysis for XSWX:BION
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:BION has been successfully added to your 
